Automation and the single-gene disorder: cystic fibrosis as a model
Silverman, L.M.; Highsmith, W.E.
Clinical Chemistry 38(1): 7-8
1992
ISSN/ISBN: 0009-9147 PMID: 1733609 Document Number: 401143
Document emailed within 1 workday
Related Documents
Bellon, G. 1998: From gene transfer to gene therapy in cystic fibrosis, how long is the road? La Revue du Praticien 48(1): 5-8Denter, M.; Ramsay, M.; Jenkins, T. 1992: Cystic fibrosis. Part I. Frequency of the delta F508 mutation in South African families with cystic fibrosis South African Medical Journal 82(1): 7-10
Tirouvanziam, R.; Desternes, M.; Saari, A.; Puchelle, E.; Péault, B.; Chinet, T. 1998: Bioelectric properties of human cystic fibrosis and non-cystic fibrosis fetal tracheal xenografts in SCID mice American Journal of Physiology 274(4): C875-C882
Flotte, T.R. 1999: Gene therapy for cystic fibrosis Current Opinion in Molecular Therapeutics 1(4): 510-516
Kere, J. 1990: Isolation of the cystic fibrosis gene Duodecim; Laaketieteellinen Aikakauskirja 106(2): 157-159
Ferec, C. 1988: Haplotypes associated with the cystic fibrosis gene (CF) Journal de Genetique Humaine 36(5): 413-424
Bargon, J.; Buhl, R. 1996: Strategies for gene therapy in cystic fibrosis Pneumologie 50(8): 562-568
Boyd, C.A. 1990: Function of cystic fibrosis gene product Lancet 336(8720): 938
Ferec, C.; Guillermit, H.; Chaventre, A. 1991: Gene mutations of cystic fibrosis in Brittany population Pathologie-Biologie 39(6): 577-580
Yuksel, H.; Yilmaz, O. 2011: A new model for cystic fibrosis management: control concept Pneumologia 60(3): 150-154
Hutchinson, E. 1998: Highlights from symposia on gene therapy for AIDS and cystic fibrosis IDrugs: the investigational drugs journal 1(3): 268-269
Clavel, C.; Pennaforte, F.; Pigeon, F.; Mozelle, M.; Boutterin, M.C.; Duval-Binninger, I.; F-erec, C.; Birembaut, P. 1996: Epidemiologic study of the cystic fibrosis gene in the Champagne-Ardenne region Annales de Biologie Clinique 54(2): 67-74
Ravnik-Glavac, M.; Gasparini, P.; Peterlin, B.; Strukelj, M.; Glavac, D.; Canki-Klain, N.; Pignatti, P.F.; Komel, R. 1992: Cystic fibrosis gene mutations and linked RFLPs in the Slovenian population Annales de Genetique 35(2): 85-88
Parent, P.; Ferec, C.; Morin, J.F.; Chabaud, J.J. 1989: Analysis of 112 haplotypes carrying the cystic fibrosis gene. Applications in genetic counseling Journal de Genetique Humaine 37(2): 133-140
Valle, E.P.; Burgos, R.I.; Valle, J.é R.én.; Egas Béjar, D.; Ruiz-Cabezas, J.-C. 2007: Analysis of CFTR gene mutations and cystic fibrosis incidence in the Ecuadorian population Investigacion Clinica 48(1): 91-98
Caramia, G.; Gagliardini, R.; Ruffini, E.; Osimani, P.; Nobilini, A. 1995: The management of cystic fibrosis with carbocysteine lysine salt: single-blind comparative study with ambroxol hydrochloride Journal of International Medical Research 23(4): 284-293
Rosenecker, J.; Huth, S.; Rudolph, C. 2006: Gene therapy for cystic fibrosis lung disease: current status and future perspectives Current Opinion in Molecular Therapeutics 8(5): 439-445
Greil, I.; Wagner, K.; Eber, E.; Zach, M.; Rosenkranz, W. 1995: Molecular and clinical findings in Austrian cystic fibrosis patients with mutations in exon 11 of the CFTR gene Wiener Klinische Wochenschrift 107(15): 464-469
Simpson, N.; Anderson, R.; Sassi, F.; Pitman, A.; Lewis, P.; Tu, K.; Lannin, H. 2005: The cost-effectiveness of neonatal screening for cystic fibrosis: an analysis of alternative scenarios using a decision model Cost Effectiveness and Resource Allocation: C/E 3: 8
Amosenko, F.A.; Sazonova, M.A.; Kapranov, N.I.; Trubnikova, I.S.; Kalinin, V.N. 1995: Analysis of various polymorphic markers of the CFTR gene in cystic fibrosis patients and healthy donors from the Moscow region Genetika 31(4): 532-535